Percutaneous pulmonary valve implantation in grown‐up congenital heart disease patients: Insights from the Zurich experience

Abstract

PPVI with Medtronic Melody or Edwards Sapien valve conduits is safe and provides effective relief from right ventricular outflow tract obstruction or pulmonary regurgitation.

Experiencia inicial con el implante percutáneo de la válvula Melody® en un centro hospitalario de la ciudad de México

“…A finales del siglo xx, se consideró que la insuficiencia de la válvula pulmonar, una de las complicaciones usualmente descritas de la reparación quirúrgica de las CC que involucran el TSVD, sería bien tolerada por el ventrículo derecho (VD), sin embargo, la experiencia observada en años recientes ha mostrado que un número importante de pacientes evolucionan a falla cardiaca derecha, arritmias letales y muerte súbita [5][6][7][8][9] . Los criterios actuales tras la reparación del TSVD en pacientes con CC complejas como la tetralogía de Fallot incluyen criterios clínicos (clase funcional, signos de insuficiencia cardiaca) y variables funcionales del VD (fracción de eyección, volumen telesistólico [VTS] y telediastólico [VTD]) 9 .…”

Initial experience with the percutaneous implant of the Melody® valve in a hospital center in Mexico City

“…In the late 20 th century, it was thought that pulmonary valve insufficiency, one of the usually described CHD surgical repair complications that involve RVOT, would be well tolerated by the right ventricle (RV); however, experiences observed in recent years have shown that an important number of patients evolve to right heart failure, lethal arrhythmias, and sudden death [5][6][7][8][9] . Current criteria after RVOT repair in patients with complex CHD, such as tetralogy of Fallot, include clinical criteria (functional class, signs of heart failure) and RV functional variables (ejection fraction, end-systolic [ESV], and end-diastolic volume [ESV]) 9 .…”

“…Since most patients with CHD that involves RVOT will require reoperation during their lifetime, the need for options to improve approaching strategies and decrease primary correction reoperation complications was a reason for the development of new technologies aiming to restore the blood flow to the pulmonary circulation, with percutaneous technology appearing for the implantation of pulmonary bioprostheses [1][2][3][4][5][6][7][8][9] .…”

“…The Melody ® valve consists of a 34-mm platinum-iridium bare stent (CP stent, NuMED Inc.; Hopkinton, New York, USA), with one valve made with a bovine jugular vein segment. The device is attached to a balloon catheter and released on a 22-Fr sleeve [1][2][3][4][5][6][7][8][9][10] . Despite its size, the use of the Melody ® valve was intended for those patients with RVOT diameters of < 24 mm, which limited the benefit to a specific group of patients.…”

Editorial: Percutaneous pulmonary valve implantation: Better technology is on the way!

“…In this issue of the Journal of Interventional Cardiology, Oechslin et al report the first published Swiss experience with tPVR in adult patients with congenital heart disease. This is a single center study addressing the feasibility, safety and efficacy of tPVR.…”